BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32102128)

  • 21. ALK-rearranged renal cell carcinomas in Polish population.
    Gorczynski A; Czapiewski P; Korwat A; Budynko L; Prelowska M; Okon K; Biernat W
    Pathol Res Pract; 2019 Dec; 215(12):152669. PubMed ID: 31677810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report.
    Yu L; Li J; Xu S; Navia Miranda M; Wang G; Duan Y
    Diagn Pathol; 2016 Oct; 11(1):98. PubMed ID: 27733182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALK-rearranged renal cell carcinomas in children.
    Cajaiba MM; Jennings LJ; Rohan SM; Perez-Atayde AR; Marino-Enriquez A; Fletcher JA; Geller JI; Leuer KM; Bridge JA; Perlman EJ
    Genes Chromosomes Cancer; 2016 May; 55(5):442-51. PubMed ID: 26773439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ALK rearrangements-associated renal cell carcinoma (RCC) with unique pathological features in an adult.
    Jeanneau M; Gregoire V; Desplechain C; Escande F; Tica DP; Aubert S; Leroy X
    Pathol Res Pract; 2016 Nov; 212(11):1064-1066. PubMed ID: 27554841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The translocation carcinoma: A pediatric renal tumor also in adults].
    Bruder E; Moch H
    Pathologe; 2016 Mar; 37(2):159-65. PubMed ID: 26972595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinicopatholigic features of renal cell carcinoma associated with chromosome X inversion harboring gene fusions involving TFE3].
    Zhao YN; Wang XT; Xia QY; Wang GP; Sun SY; Zhao LF; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):574-579. PubMed ID: 30107660
    [No Abstract]   [Full Text] [Related]  

  • 27. Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH.
    Xia QY; Wang XT; Ye SB; Wang X; Li R; Shi SS; Fang R; Zhang RS; Ma HH; Lu ZF; Shen Q; Bao W; Zhou XJ; Rao Q
    Histopathology; 2018 Apr; 72(5):786-794. PubMed ID: 29148086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ALK-rearranged renal cell carcinoma (ALK-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey.
    Doğan K; Onder E
    Pathol Res Pract; 2024 Jan; 253():154951. PubMed ID: 38039739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum.
    Debelenko LV; Raimondi SC; Daw N; Shivakumar BR; Huang D; Nelson M; Bridge JA
    Mod Pathol; 2011 Mar; 24(3):430-42. PubMed ID: 21076462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anaplastic lymphoma kinase-translocation renal cell carcinoma: clinical and pathological analysis].
    Di SH; Wang XT; Xia QY; Lu ZF; Ma HH; Zhang RS; Wang X; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):28-32. PubMed ID: 34979750
    [No Abstract]   [Full Text] [Related]  

  • 31. VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?
    Smith NE; Deyrup AT; Mariño-Enriquez A; Fletcher JA; Bridge JA; Illei PB; Netto GJ; Argani P
    Am J Surg Pathol; 2014 Jun; 38(6):858-63. PubMed ID: 24698962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients.
    Sukov WR; Hodge JC; Lohse CM; Akre MK; Leibovich BC; Thompson RH; Cheville JC
    Mod Pathol; 2012 Nov; 25(11):1516-25. PubMed ID: 22743654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.
    van der Krogt JA; Bempt MV; Ferreiro JF; Mentens N; Jacobs K; Pluys U; Doms K; Geerdens E; Uyttebroeck A; Pierre P; Michaux L; Devos T; Vandenberghe P; Tousseyn T; Cools J; Wlodarska I
    Haematologica; 2017 Sep; 102(9):1605-1616. PubMed ID: 28659337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
    Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
    Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.
    Kato I; Furuya M; Baba M; Kameda Y; Yasuda M; Nishimoto K; Oyama M; Yamasaki T; Ogawa O; Niino H; Nakaigawa N; Yano Y; Sakamoto K; Urata Y; Mikami K; Yamasaki S; Tanaka R; Takagi T; Kondo T; Nagashima Y
    Histopathology; 2019 Aug; 75(2):254-265. PubMed ID: 30908700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review.
    Iannantuono GM; Riondino S; Sganga S; Roselli M; Torino F
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
    Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral Xp11.2 translocation renal cell carcinoma: a case report.
    Karashima T; Kuno T; Kuroda N; Satake H; Fukata S; Chikazawa M; Kawada C; Yamasaki I; Shuin T; Hiroi M; Inoue K
    BMC Urol; 2018 Nov; 18(1):106. PubMed ID: 30458744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: Identification of a novel HOOK1-ALK fusion transcript.
    Cajaiba MM; Jennings LJ; George D; Perlman EJ
    Genes Chromosomes Cancer; 2016 Oct; 55(10):814-7. PubMed ID: 27225638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.